Home

Morepen Laboratories Ltd EPS

Image

Morepen Laboratories Ltd

NSE: MOREPENLAB

EPS

₹ 2.3

Last updated on: Mar 28, 2025

Key Highlights

  • The Earning per Share of Morepen Laboratories Ltd is ₹ 2.3 as of 28 Mar 25 .
  • The earning per share of Morepen Laboratories Ltd changed from ₹ 0.29 to ₹ 0.49 over 7 quarters. This represents a CAGR of 34.95% .

Historical Earning per Share of Morepen Laboratories Ltd

No data available

* All values are in

Company Fundamentals for Morepen Laboratories Ltd

Market Cap

2,621 Cr

EPS

2.3

P/E Ratio (TTM)

20.8

P/B Ratio (TTM)

2.4

Day’s High

49.7

Day’s Low

47.81

DTE

0.0

ROE

11.8

52 Week High

100.8

52 Week Low

42.0

ROCE

16.2

Market Price of Morepen Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Morepen Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
28 Mar 202547.85
27 Mar 202548.54
26 Mar 202547.47
25 Mar 202549.62
24 Mar 202551.72
21 Mar 202550.21
20 Mar 202548.69
19 Mar 202549.42
18 Mar 202548.11
17 Mar 202542.8

SWOT Analysis Of Morepen Laboratories Ltd

Strength

2

che

Weakness

2

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Morepen Laboratories Ltd

Asset Value vs Market Value of Morepen Laboratories Ltd

Market Value

2,622

Asset Value

Value addition

1.9 X

899

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Morepen Laboratories Ltd2621
Sun Pharmaceutical Industries Ltd416393
Divis Laboratories Ltd153258
Cipla Ltd116434
Torrent Pharmaceuticals Ltd109469
Mankind Pharma Ltd99974

Historical Market Cap of Morepen Laboratories Ltd

No data available

* All values are in crore

Historical Revenue of Morepen Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Morepen Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Morepen Laboratories Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Morepen Laboratories Ltd News Hub

Morepen Labs soars after stellar Q1 performance

Net revenue increased by 14% year-over-year (YoY) to Rs 458.64 crore during the period under review.

Read more

12 Aug 24

Morepen Laboratories consolidated net profit rises 147.23% in the June 2024 quarter

Net profit of Morepen Laboratories rose 147.23% to Rs 36.17 crore in the quarter ended June 2024 as

Read more

12 Aug 24

Morepen Laboratories to announce Quarterly Result

Morepen Laboratories will hold a meeting of the Board of Directors of the Company on 12 August 2024.

Read more

10 Aug 24

Morepen Laboratories successfully concludes QIP issue of Rs 200 cr

Morepen Laboratories announced the successful subscription of a Qualified Institutional Placement (Q

Read more

06 Aug 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Morepen Laboratories Ltd

What is the EPS of Morepen Laboratories Ltd stock?

The Earnings Per Share (EPS) of Morepen Laboratories Ltd is 2.3. An EPS is the amount of net income attributed to each share of a common stock.

How is Morepen Laboratories Ltd EPS calculated?

The EPS of Morepen Laboratories Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Morepen Laboratories Ltd report its EPS?

Morepen Laboratories Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Morepen Laboratories Ltd EPS?

Factors that influence the EPS of Morepen Laboratories Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Morepen Laboratories Ltd EPS growth indicate future performance?

Yes, consistent growth in Morepen Laboratories Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions